Industry

Promising efficacy data in young patients with persistent increase or stabilization in 3 main developmental domains (cognition, motor and language) in all patients enrolled under the age of 30 months Final and comprehensive results of the 24 months pivotal data for the main cohort are expected in Q3 2022 along with the results of the … [Read more…]

KAISERSLAUTERN, Germany–(BUSINESS WIRE)–Freudenberg Medical, a manufacturer of medical and pharmaceutical devices, components and tubing, has introduced HelixFlex™, a high purity thermoplastic elastomer TPE tubing designed for use in pharmaceutical and biopharmaceutical applications. This is an expanded offering from Freudenberg, adding to its existing pharma product portfolio of silicone tubing and fluid transfer products for bioprocessing, … [Read more…]

Anterra Capital’s second Global Food and Agriculture Technology Fund closes at $260 million, oversubscribed thanks to robust institutional demand AMSTERDAM & BOSTON–(BUSINESS WIRE)–A crushing pandemic and, more recently, the Ukraine war have convinced investors more than ever that the world needs to radically change how it produces, distributes and consumes food, says Adam Anders, managing … [Read more…]

Setting Higher Standard of Safety & Comfort to our customers in Singapore from Melo! @Funan Mall SINGAPORE–(BUSINESS WIRE)–During Post-Covid regime in Singapore, with Innovation & Technology from Japan, now Melo, managed by Global Partners Consulting Group (HQ: Singapore; Managing Director: Zenta Nishida), is introducing the brand-new sterilized retail shop in Singapore to ensure its customers … [Read more…]

Gilead Protest, Wednesday, May 18th, 12:00 pm Foster City, CA In March, Gilead imposed conditions illegally restricting access on 340B drug pricing to its branded hepatitis C treatments when covered entities use outside contract pharmacies. Gilead has the ignominious distinction of being the 15th manufacturer to place similar unlawful restrictions on certain 340B contract pharmacy … [Read more…]

City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumors. SYDNEY & LOS ANGELES–(BUSINESS WIRE)–Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed … [Read more…]

Device Intended to Reduce Risk of IV Catheter Failure and Replacement in Hospitals; Sister Product Orchid SRV-Type D for Drainage to Launch Simultaneously OKLAHOMA CITY–(BUSINESS WIRE)–#FDA–Please replace the release with the following corrected version due to the removal of paragraph eight (“Linear Health Sciences won an Innovative Technology Award for Orchid SRV from Vizient, and … [Read more…]

WASHINGTON–(BUSINESS WIRE)–The College of American Pathologists (CAP) President Emily Volk, MD, FCAP, released the following statement regarding the draft Food and Drug Administration (FDA) user fee authorization bill by the Senate Health, Education, Labor, and Pensions (HELP) Committee. The discussion draft of the bill includes sections of the Verifying Accurate Leading-edge IVCT Development (VALID) Act … [Read more…]

AUSTIN, Texas–(BUSINESS WIRE)–#carbonfootprint–Businesses are being held accountable for their environmental impact. Some companies have taken a proactive approach by announcing their plans to reach net zero, while others are considering more modest reductions to reduce operational expenditures. A few weeks ago, the Securities and Exchange Commission (SEC) issued a proposal requiring public companies to disclose … [Read more…]

FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, plans to present a company overview at the H.C. Wainwright Global Investment Conference. The presentation will be available as an … [Read more…]